Tumor Infiltrating Lymphocytes（Fujian Cancer Hospital）

肿瘤浸润淋巴细胞（福建省肿瘤医院）

Report date: 2023/02/16 20:00:58

Base Information

Drug NameTumor Infiltrating Lymphocytes（Fujian Cancer Hospital）

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionLymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesFujian Cancer Hospital

China Registration ClassN/A

Develop Information

Active CompaniesFujian Cancer Hospital

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A